Navigation Links
A Recent Study by ITG's Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
Date:6/1/2011

NEW YORK, June 1, 2011 /PRNewswire/ -- A study published this week by ITG's Majestic Market Research revealed that Novartis' recently approved drug, Gilenya, continues to steal share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  Gilenya came onto the market in late September 2010 as the first FDA-approved oral disease-modifying MS drug.  Despite negative sentiment around Gilenya's lengthy initiation process, neurologists are embracing the new drug at an impressive rate.  Real time data from ITG's proprietary physician panel indicate that Gilenya was the disease-modifying treatment of choice for 20% of new written MS prescriptions in April.  Furthermore, surveyed neurologists indicated that their prescribing of Gilenya will increase significantly over the course of 2011 as they continue to shift inadequate responders from other MS therapies to the new drug.

The study takes an in-depth look at how Gilenya's multi-step initiation process is impacting neurologists' use of the drug.  According to neurologists, new treatment starts for Gilenya typically take between three to six weeks and involve the scheduling and organization of prescreening tests and ongoing monitoring for adverse events.  

Physicians reported that Novartis plays an important role in facilitating these steps. In fact, 63% of Gilenya prescribers indicated that they receive support from Novartis during this process, and 25% of them classified this assistance as superior to what competing companies offer for their products.  

By comparison, neurologists appear unable to get over similar concerns about Acorda Therapeutics' Ampyra, which was launched in March 2010 as the first FDA approved drug to improve walking in MS patients. Like Gilenya, Ampyra is associated with an onerous initi
'/>"/>

SOURCE ITG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
4. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
5. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
6. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
11. Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , 31 mars 2015  Une équipe de ... structure atomique d,un récepteur de surface cellulaire ... formation de thromboses. Contre toute attente, cette ... nouvelles caractéristiques structurelles qui remettent en cause ... sur les récepteurs couplés aux protéines G ...
(Date:3/30/2015)... Va. , March 30, 2015  Researchers ... the Marshall University Joan C. Edwards School of ... entitled, "PSEN1 Variant in a Family with Atypical ... genetically confirmed to have a known variant of ... drug Bryostatin 1. Genetically confirmed Alzheimer,s patients as ...
(Date:3/30/2015)... NEW YORK , March 30, 2015  Check-Cap ... diagnostics company focused on the development of a preparation-free ... screening for colorectal cancer, announced today that its CEO, ... the March 31, 2015 trading day.  Neev and Check-Cap ... to commemorate the company,s initial public offering and simultaneous ...
Breaking Medicine Technology:De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 2De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 2Severe Alzheimer's Patient Responds to Bryostatin Treatment 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 4Severe Alzheimer's Patient Responds to Bryostatin Treatment 5Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3
... 2011 Novus Scientific Pte. Ltd today announced that it ... of receiving its anticipated CE Mark approval this year for ... 1st Long-Term Resorbable Synthetic Mesh. To mark the ... 11th 2011 at the Zebrastraat venue in Ghent  ( http://www.novusscientific.com/events/ ...
... Methodist West Hospital (MWH), of West Des Moines, ... Rauland,s new Responder 5 Nurse Call communication system in ... Department (ED) treatment rooms, as well as the Maternity ... wireless phones, MWH created a quiet, healing environment that ...
Cached Medicine Technology:TIGR® Matrix Surgical Mesh - Exhibited Ahead of Anticipated CE Mark Approval at European Hernia Society 2011, Ghent, Belgium 2A Quiet Healing Environment Created by Nurse Call? 2A Quiet Healing Environment Created by Nurse Call? 3A Quiet Healing Environment Created by Nurse Call? 4
(Date:3/31/2015)... . All the work that is done is performed ... upon helping our clients in maintaining their confident beautiful smiles. ... and this problem needs to be addressed as soon as ... a key role in shattering one’s confidence but they also ... importance of this problem, Lewis Clinic has started dental implants ...
(Date:3/31/2015)... 31, 2015 With nationwide predictions of ... phenomenon known as the pineapple express, the OPP is ... insurance. FEMA , "Protecting Your Business" 09/23/2014, ... tips for protecting your business. , Here are 3 ... Almost 40% of small businesses never reopen their ...
(Date:3/31/2015)... 31, 2015 Telemedicine technology is ... specialists at Barnes-Jewish Hospital to patients at Memorial ... Illinois Healthcare (SIH) system. , “Previously, when an ... maternal-fetal medicine consultation, she had to travel two ... and then talk with a Barnes-Jewish specialist,” says ...
(Date:3/30/2015)... A new legal resource site ... members who may have been prescribed Zofran, or it’s ... The site was created in response to the plea ... No. 11-10398-RWZ, filed with the United States District Court ... that this case alleged that GlaxoSmithKline gave doctors kickbacks ...
(Date:3/30/2015)... March 31, 2015 Thomas Peither ... most respected inspection readiness professionals — will conduct ... through the inspection process. , Attendees will learn ... investigator and what they look for when conducting ... exercises and roundtable discussions. This will assure attendees ...
Breaking Medicine News(10 mins):Health News:3 Statistics Every Business Owner Should Know About Flood Waters and Flood Insurance, from the Optometric Protector Plan® 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 3Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4
... known for a long time that mutual antagonism between husband ... It has now been possible to pinpoint the exact reason. ... of coronary arteries (atherosclerosis) in women while controlling behavior of ... in men. ,Dr. Tim Smith and fellow researchers ...
... cancer, new research seems to say, as vaccines for ... ingredient//. ,Vaccines work by allowing the body’s immune system ... the immune system finds it difficult to distinguish the ... researchers at University College London (UCL) have been able ...
... scientists from University of New South Wales have ... inflammatory stages of glandular fever// could lead to chronic ... be related to specific regions of the brain that ... fatigue. An acute glandular fever infection could damage ...
... from a crippling mosquito-borne virus disease the Chikungunya fever. It ... area//. The World Health Organization (WHO) said that the ... Ocean region. ,This disease has no cure or ... Mauritius and Seychelles since January. The disease was first recognized ...
... it was found that GlaxoSmithKline Plc which funded the ... in infants// said that the vaccine was viable. GlaxoSmithKline ... ,Roman Prymula, who led the study at the Czech ... necessary before the vaccine hits the market. ...
... Trust plastic surgeons to be greedier! Not satisfied with ... a French woman, plastic surgeons are hungry to perform ... March issue of Plastic and Reconstructive Surgery? (PRS), the ... Surgeons (ASPS), U.S. plastic surgeons demonstrated the procedure of ...
Cached Medicine News:Health News:Heart disease: Men Are From Mars, Women From Venus 2Health News:Brain Injury, A Consequence Of Glandular Fever Could Trigger Fatigue Syndrome 2Health News:Threat from Chikungunya, No Longer a Fear 2
... Horizontal Mini Gel Kit. Gel ... one comb and tapered baffles for casting ... UV transparent. Available in clear, blue, ... supplies, gel trays, gel casters, single and ...
... advantages for nucleic acid separation, and have ... biologist. Agarose gels are easy to cast ... sample underlaying and prevent electrical field discontinuities ... Horizontal systems are more economical and easier ...
... The Mini-Sub cell GT system, ... is used for submerged horizontal gel ... format 7 x 10 cm agarose ... cell, 7 x 10 cm UV-transparent ...
Wide Mini ReadySub-Cell GT Cell, includes buffer tank, lid and electrodes, leveling bubble; accommodates 20-well, 32-well, and 2 x 32-well wide mini ReadyAgarose gels...
Medicine Products: